Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-13-003668
Filing Date
2013-08-14
Accepted
2013-08-14 11:52:16
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q phrx_10q.htm 10-Q 817639
2 CERTIFICATION phrx_ex311.htm EX-31.1 15583
3 CERTIFICATION phrx_ex312.htm EX-31.2 15848
4 CERTIFICATION phrx_ex321.htm EX-32.1 6312
5 CERTIFICATION phrx_ex322.htm EX-32.2 6396
  Complete submission text file 0001477932-13-003668.txt   5472170

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT phrx-20130630.xml EX-101.INS 384788
7 XBRL TAXONOMY EXTENSION SCHEMA phrx-20130630.xsd EX-101.SCH 41078
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phrx-20130630_cal.xml EX-101.CAL 41090
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phrx-20130630_def.xml EX-101.DEF 91901
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE phrx-20130630_lab.xml EX-101.LAB 260040
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phrx-20130630_pre.xml EX-101.PRE 183606
Mailing Address 9337 FRASER AVE. SILVER SPRING MD 20910
Business Address 9337 FRASER AVE. SILVER SPRING MD 20910 (204) 898-8160
Pharmagen, Inc. (Filer) CIK: 0001470915 (see all company filings)

EIN.: 270777112 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54523 | Film No.: 131036089
SIC: 1000 Metal Mining